Use this Interactive Decision Support Tool to obtain strategies to assess and manage CAR T-cell therapy–associated toxicities from 5 renowned multidisciplinary experts.
Review expert insights and recommendations on the evolving multidisciplinary management of cytokine-release syndrome and neurotoxicity associated with CAR T-cell therapies.
In this downloadable slideset with slidenotes featuring expert commentary, review the biologic principles underlying toxicities associated with CAR T-cell therapy and how to leverage multidisciplinary strategies to manage these unique adverse events.
A resource guide describing how CAR T-cells are manufactured, approved CAR T-cell therapies, tips on screening/diagnosis/monitoring, and guidance on managing CAR T-cell-associated toxicities.
Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112
Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.